New Key Statistics Module, Z-Score and F-Score
NAS:ARWR Key Ratios
| Market Cap $ M | 3,090.10 |
| Enterprise Value $ M | 2,685.91 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 6.38 |
| Price/Sales | 75.17 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 35.00 |
| EPS (TTM) $ | -4.24 |
| Beneish M-Score | -6.57 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -5.90 |
| EV-to-EBITDA | -6.12 |
| PEG | -- |
| Shares Outstanding M | 124.20 |
| Net Margin (%) | -1,327.18 |
| Operating Margin % | -1,335.58 |
| Pre-tax Margin (%) | -1,347.67 |
| Quick Ratio | 8.31 |
| Current Ratio | 8.31 |
| ROA % (ttm) | -58.35 |
| ROE % (ttm) | -136.29 |
| ROIC % (ttm) | -126.49 |
| Dividend Yield % | -- |
| Altman Z-Score | 1.21 |
ARWR Number of Guru Trades
ARWR Volume of Guru Trades
Gurus Latest Trades with NAS:ARWR
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ARWR is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Arrowhead Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:ARWR
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers